Thrombotic thrombocytopenic purpura--coagulation parameters in twelve patients.
D000293:Adolescent; D000328:Adult; D000743:Anemia, Hemolytic / Q000150:complications; D000941:Antigens / Q000032:analysis; D001241:Aspirin / Q000627:therapeutic use; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D001856:Bone Marrow Examination; D004176:Dipyridamole / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005938:Glucocorticoids / Q000627:therapeutic use; D006385:Hemagglutination Inhibition Tests; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000473:pathology / Q000628:therapy; D013154:Spleen / Q000473:pathology; D013156:Splenectomy
D000941:Antigens; D005938:Glucocorticoids; D004176:Dipyridamole; D005340:Fibrinogen; D006493:Heparin; D001241:Aspirin